How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to ‘non-aggressive’ DMARD treatment and perspective from a 2-yr open label trial.

Autor: T. J. H. Christianson, R. L. McClelland
Zdroj: Rheumatology; Vol. 43 Issue 5, p619-625, 7p
Databáze: Complementary Index